Tefferi A - Search Results

1

Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis.

Tefferi A, Guglielmelli P, Larson DR, Finke C, Wassie EA, Pieri L, Gangat N, Fjerza R, Belachew AA, Lasho TL, Ketterling RP, Hanson CA, Rambaldi A, Finazzi G, Thiele J, Barbui T, Pardanani A, Vannucchi AM. Tefferi A, et al. Blood. 2014 Oct 16;124(16):2507-13; quiz 2615. doi: 10.1182/blood-2014-05-579136. Epub 2014 Jul 18. Blood. 2014. PMID: 25037629 Free PMC article.

2

Issues in the diagnosis and management of essential thrombocythemia.

Tefferi A, Hoagland HC. Tefferi A, et al. Mayo Clin Proc. 1994 Jul;69(7):651-5. doi: 10.1016/s0025-6196(12)61342-1. Mayo Clin Proc. 1994. PMID: 8015328 Review.

3

The 5q- syndrome: a single-institution study of 43 consecutive patients.

Mathew P, Tefferi A, Dewald GW, Goldberg SL, Su J, Hoagland HC, Noel P. Mathew P, et al. Among authors: tefferi a. Blood. 1993 Feb 15;81(4):1040-5. Blood. 1993. PMID: 8427985 Free article.

4

Spectrum of diseases associated with increased proportions or absolute numbers of peripheral blood natural killer cells.

Okuno SH, Tefferi A, Hanson CA, Katzmann JA, Li CY, Witzig TE. Okuno SH, et al. Among authors: tefferi a. Br J Haematol. 1996 Jun;93(4):810-2. Br J Haematol. 1996. PMID: 8703808

5

Heterogeneity and clinical relevance of the intensity of CD20 and immunoglobulin light-chain expression in B-cell chronic lymphocytic leukemia.

Tefferi A, Bartholmai BJ, Witzig TE, Li CY, Hanson CA, Phyliky RL. Tefferi A, et al. Am J Clin Pathol. 1996 Oct;106(4):457-61. doi: 10.1093/ajcp/106.4.457. Am J Clin Pathol. 1996. PMID: 8853032

6

Acquired von Willebrand's disease due to aberrant expression of platelet glycoprotein Ib by marginal zone lymphoma cells.

Tefferi A, Hanson CA, Kurtin PJ, Katzmann JA, Dalton RJ, Nichols WL. Tefferi A, et al. Br J Haematol. 1997 Mar;96(4):850-3. doi: 10.1046/j.1365-2141.1997.d01-2088.x. Br J Haematol. 1997. PMID: 9074430 Free article.

7

Clinical correlations of immunophenotypic variations and the presence of trisomy 12 in B-cell chronic lymphocytic leukemia.

Tefferi A, Bartholmai BJ, Witzig TE, Jenkins RB, Li CY, Hanson CA, Mesa RA, Phyliky RL. Tefferi A, et al. Cancer Genet Cytogenet. 1997 Jun;95(2):173-7. doi: 10.1016/s0165-4608(96)00249-x. Cancer Genet Cytogenet. 1997. PMID: 9169037 Review.

8

New drugs in essential thrombocythemia and polycythemia vera.

Tefferi A, Elliott MA, Solberg LA Jr, Silverstein MN. Tefferi A, et al. Blood Rev. 1997 Mar;11(1):1-7. doi: 10.1016/s0268-960x(97)90001-1. Blood Rev. 1997. PMID: 9218101 Review.

9

Interferon-alpha therapy in polycythemia vera and essential thrombocythemia.

Elliott MA, Tefferi A. Elliott MA, et al. Among authors: tefferi a. Semin Thromb Hemost. 1997;23(5):463-72. doi: 10.1055/s-2007-996123. Semin Thromb Hemost. 1997. PMID: 9387205 Review.

10

Pathogenetic mechanisms in chronic myeloproliferative disorders: polycythemia vera, essential thrombocythemia, agnogenic myeloid metaplasia, and chronic myelogenous leukemia.

Tefferi A. Tefferi A. Semin Hematol. 1999 Jan;36(1 Suppl 2):3-8. Semin Hematol. 1999. PMID: 9930550 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,188 results

Search Page

Filters